Top Story

NYU Langone appoints neuro-oncology chief

August 30, 2015

Andrew S. Chi, MD, PhD, has been appointed chief of neuro-oncology at NYU Langone Medical Center’s Laura and Isaac Perlmutter Cancer Center.

Chi, a physician-scientist and brain tumor specialist, also will serve as co-director of the NYU Langone Brain Tumor Center.

Institution Notes

MD Anderson appoints orthopedic oncology department chair

August 29, 2015
Valerae O. Lewis, MD, has been named chair of the department of orthopedic oncology at The University of Texas MD Anderson Cancer Center.Lewis, whose clinical focus is…
Timothy J. Ley, MD In the Journals

Persistent mutations may predict EFS, OS outcomes in AML

August 28, 2015
Persistent leukemia-associated mutations in at least 5% of bone marrow cells in day 30 remission samples appeared to significantly increase the risk for relapse and…
Allison W. Kurian, MD, MSc In the Journals

Impact of recurrence score assay on chemotherapy receipt varies based on breast cancer risk

August 28, 2015
The use of a 21-gene recurrence score assay appeared associated with greater use of chemotherapy in patients with low-risk breast cancer and a reduced use of…
More News Headlines »
Health Care Legislative and Regulatory Update Publication Exclusive
Medicare fraud takedown: A closer look

Medicare fraud takedown: A closer look

Spine Surgery Today, July/August 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and…
More »
Meeting News Coverage Video
VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated…
More »